#San Francisco

Based on surveys conducted in 2015 and 2018, the number appears to have nearly tripled in San Francisco.

Senator Scott Wiener’s legislation would set statewide policy and goals. For now, it doesn’t seek funding.

The city has focused its efforts on mobile outreach.

Surprise: GOP health chief backs needle exchanges as prevention. But the health secretary does not support safe injection sites.

For over 30 years, the California-based group fought for treatments, research, education and quality health care.

He said it would enable drug use, but Jeff Sessions also influenced the veto.

The harm reduction facility could be the first in the nation.

The group focuses on treatment, research, policy and education around HIV and hepatitis C.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

The Bay Area city follows on the heels of Philadelphia and Seattle.

The city’s department of health says a new harm reduction facility could open in as little as eight months.

The death toll is now up to 16, and an additional 292 people have been hospitalized since November.

Nearly 13,000 San Francisco residents are currently living with hepatitis C virus (HCV).

Advocates estimate that nearly 13,000 of the city’s residents have an HCV infection.

Widespread treatment offers the possibility of eliminating hepatitis C as a public health threat.

The National Alliance of State & Territorial AIDS Directors welcomes CDC-funded local jurisdictions. [VIDEO]